Clin2
NCT07396194Possibly a fitNot yet recruiting

Study of ankylosing spondylitis treatment options

Ankylosing Spondylitis

Part of Bones, joints & muscles clinical trials.

This study looks at treatments for people with ankylosing spondylitis, a type of arthritis that affects the spine. It aims to find better ways to manage symptoms and improve quality of life.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
84 people
Ages
16 years to 80 years
Study type
Observational

Who can take part

  • You have been diagnosed with ankylosing spondylitis by a doctor.
  • Your condition can be active (causing symptoms) or stable (well-controlled).
  • You do not have other autoimmune diseases, diabetes, infections, or cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07166874Recruiting
Gluten-free diet for ankylosing spondylitis

This study looks at how a gluten-free diet affects people with ankylosing spondylitis (a type of arthritis that mainly affects the spine). You would eat no gluten (found in wheat, barley, and rye) for a period of time to see if it helps reduce symptoms.

Istanbul
NCT07261644Recruiting· Phase 3
Study of a new drug for active ankylosing spondylitis

This study tests a new medication (called 608) for adults with active ankylosing spondylitis (AS). It aims to see if the drug can reduce AS symptoms and improve quality of life.

Beijing, Beijing Municipality
NCT06642207Recruiting
Comparing two biologic drugs for ankylosing spondylitis

This study compares two types of biologic drugs (IL-17 inhibitors vs. anti-TNF drugs) in people with ankylosing spondylitis (a form of arthritis affecting the spine) who have already tried standard treatments. The goal is to see which drug works better for controlling symptoms.

Sohag
NCT06833112Not yet recruiting· Phase 4
Combination biologic therapy for ankylosing spondylitis

This trial tests whether combining two biologic medications (adalimumab and secukinumab) can better relieve symptoms of ankylosing spondylitis, a type of arthritis that affects the spine. It may help if you have not responded well to standard nonsteroidal anti-inflammatory drugs (NSAIDs) and you have active disease.

Guiyang, Guizhou
NCT07632599Not yet recruiting· Phase 1
Stem cell treatment for active ankylosing spondylitis

This trial tests whether a single infusion of stem cells from a healthy donor's bone marrow can help reduce inflammation and pain in people with active ankylosing spondylitis. If you are young and have not been helped by standard treatments, this study might offer a new option.

Shenzhen, Guangdong
NCT07510789Recruiting
Low back pain impact in ankylosing spondylitis

This study looks at how different types of low back pain in people with ankylosing spondylitis affect their daily functioning and overall well-being. It aims to better understand these pain patterns so doctors can provide more personalized care.

Konya, Selçuklu

Hear when a new Ankylosing Spondylitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.